0001209191-23-009938.txt : 20230215
0001209191-23-009938.hdr.sgml : 20230215
20230215203025
ACCESSION NUMBER: 0001209191-23-009938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230214
FILED AS OF DATE: 20230215
DATE AS OF CHANGE: 20230215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVIN ARTHUR A
CENTRAL INDEX KEY: 0001181556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39321
FILM NUMBER: 23636918
MAIL ADDRESS:
STREET 1: 1896 RUTHERFORD ROAD
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avidity Biosciences, Inc.
CENTRAL INDEX KEY: 0001599901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461336960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE
STREET 2: SUITE 125
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-401-7900
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE
STREET 2: SUITE 125
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity Biosciences LLC
DATE OF NAME CHANGE: 20161227
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity NanoMedicines LLC
DATE OF NAME CHANGE: 20140211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-14
0
0001599901
Avidity Biosciences, Inc.
RNA
0001181556
LEVIN ARTHUR A
C/O AVIDITY BIOSCIENCES, INC.
10578 SCIENCE CENTER DRIVE, SUITE 125
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2023-02-14
4
M
0
10000
1.24
A
29330
D
Common Stock
2023-02-14
4
S
0
9477
23.6246
D
19853
D
Common Stock
2023-02-14
4
S
0
523
24.2381
D
19330
D
Common Stock
273872
I
By family trust
Stock Option (Right to Buy)
1.24
2023-02-14
4
M
0
10000
0.00
D
2030-02-18
Common Stock
10000
68423
D
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.16 to $24.08 per share. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $24.16 to $24.30 per share. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
25% of the shares subject to the option vested on February 19, 2021, and 1/48th of the shares subject to the option will vest monthly thereafter.
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
2023-02-15